Association between Vascular Endothelial Growth Factor Gene Polymorphisms and Pre-Eclampsia Susceptibility: An Updated Meta-Analysis

References

• Amin-Beidokhti M, Gholami M, Abedin-Do A, Pirjani R, Sadeghi H, Karamoddin F, Yassaee VR, Mirfakhraie R. 2018. An intron variant in the FLT1 gene increases the risk of preeclampsia in Iranian women. Clin Exp Hypertens. 1–5. doi:10.1080/10641963.2018.1539097
   PubMedGoogle Scholar
• Amosco MD, Villar VA, Naniong JM, David-Bustamante LMG, Jose PA, Palmes-Saloma CP. 2016. VEGF-A and VEGFR1 SNPs associate with preeclampsia in a Philippine population. Clin Exp Hypertens. 38:578–85.
   PubMed Web of Science ®Google Scholar
• Andraweera PH, Dekker GA, Dissanayake VH, Bianco-Miotto T, Jayasekara RW, Roberts CT. 2013. Vascular endothelial growth factor family gene polymorphisms in preeclampsia in Sinhalese women in Sri-Lanka. J Matern Fetal Neonatal Med. 26:532–36.
   PubMed Web of Science ®Google Scholar
• Atis A, Oruc O, Aydin Y, Cetincelik U, Goker N. 2012. Vascular endothelial growth factor gene +813CC polymorphism of foetus is associated with preterm labour but not with pre-eclampsia in Turkish pregnant women. Int J Immunogenet. 39:241–46.
   PubMed Web of Science ®Google Scholar
• Bányász I, Szabó S, Bokodi G, Vannay A, Vasarhelyi B, Szabo A, Tulassay T, Rigo J. 2006. Genetic polymorphisms of vascular endothelial growth factor in severe pre-eclampsia. Mol Human Reprod. 12:233–36.
   PubMed Web of Science ®Google Scholar
• Ben Ali Gannoun M, Al-Madhi SA, Zitouni H, Raguema N, Meddeb S, Hachena Ben Ali F, Mahjoub T, Almawi WY. 2017. Vascular endothelial growth factor single nucleotide polymorphisms and haplotypes in pre-eclampsia: A case-control study. Cytokine. 97:175–80.
   PubMed Web of Science ®Google Scholar
• Brownbill P, Mills TA, Soydemir DF, Sibley CP. 2008. Vasoactivity to and endogenous release of vascular endothelial growth factor in the in vitro perfused human placental lobule from pregnancies complicated by preeclampsia. Placenta. 29:950–55.
   PubMed Web of Science ®Google Scholar
• Chedraui P, Solis EJ, Bocci G, Gopal S, Russo E, Escobar GS, Hidalgo L, Pérez-López FR, Genazzani AR, Mannella P, et al. 2013. Feto-placental nitric oxide, asymmetric dimethylarginine and vascular endothelial growth factor (VEGF) levels and VEGF gene polymorphisms in severe preeclampsia. J Matern Fetal Neonatal Med. 26:226–32.
   PubMed Web of Science ®Google Scholar
• Chen BL, Wang YY, Li GR, Song HC, Zuo JL. 2011. Analysis on gene polymorphism of vascular endothelial growth factor and susceptibility of severe preeclampsia. Maternal Child Health Care China. 26:5052–55.
   Google Scholar
• Cheng DY, Hao YW, Zhou WL, Ma Y, Szecsi PB. 2013. Vascular endothelial growth factor +936C/T, −634G/C, −2578C/A, and −1154G/A polymorphisms with risk of preeclampsia: a meta-analysis. PLoS One. 8:e78173.
   PubMed Web of Science ®Google Scholar
• Cunha VM, Grecco RL, Paschoini MC, Silva SRD, Ruiz MT, Balarin MAS. 2011. Genetic polymorphisms of vascular endothelial growth factor in pre-eclampsia. Rev Bras Ginecol Obstet. 33:158–63.
   PubMedGoogle Scholar
• Egger M, Smith GD, Schneider M, Minder C. 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ. 315:629–34.
   PubMed Web of Science ®Google Scholar
• El-Sonbati AZ, El-Baz RA, Saad EA, El-Zekred AS. 2014. Vascular endothelial growth factor VEGF G/C 405 and C/A 2578 gene polymorphisms in cases with pre-eclampsia. Int J Pharm Pharm Sci. 6:281–84.
   Google Scholar
• Galazios G, Papazoglou D, Tsikouras P, Kolios G. 2009. Vascular endothelial growth factor gene polymorphisms and pregnancy. J Matern Fetal Neonatal Med. 22:371–78.
   PubMed Web of Science ®Google Scholar
• Garza-Veloz I, Castruita-De la Rosa C, Cortes-Flores R, Martinez-Gaytan V, Rivera-Muñoz JE, Garcia-Mayorga EA, Meza-Lamas E, Rojas-Martinez A, Ortiz-Lopez R, Martinez-Fierro ML. 2011. No association between polymorphisms/haplotypes of the vascular endothelial growth factor gene and preeclampsia. BMC Pregnancy Childbirth. 11(1):35.
   PubMedGoogle Scholar
• Hu YF, Luscher B, Admon A, Mermod N, Tjian R. 1990. Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev. 4:1741–52.
   PubMed Web of Science ®Google Scholar
• Huang YL, Liu J. 2009. Analysis on gene polymorphism of vascular endothelial growth factor and susceptibility of preeclampsia patient. Maternal Child Health Care China. 24:2712–14.
   Google Scholar
• Hunter A, Aitkenhead M, Caldwell C, McCracken G, Wilson D, McClure N. 2000. Serum levels of vascular endothelial growth factor in preeclamptic and normotensive pregnancy. Hypertension. 36:965–69.
   PubMed Web of Science ®Google Scholar
• Karaman S, Leppänen VM, Alitalo K 2018. Vascular endothelial growth factor signaling in development and disease. Development. 145(dev151019). doi:10.1242/dev.151019
   PubMedGoogle Scholar
• Kim YJ, Park BH, Park H, Jung S-C, Pang M-G, Ryu H-M, Lee K-S, Eom S-M, Park H-Y. 2008. No association of the genetic polymorphisms of endothelial nitric oxide synthase, dimethylarginine dimethylaminohydrolase, and vascular endothelial growth factor with preeclampsia in Korean populations. Twin Res Hum Genet. 11:77–83.
   PubMed Web of Science ®Google Scholar
• Krippl P, Langsenlehner U, Renner W, Yazdani-Biuki B, Wolf G, Wascher TC, Paulweber B, Haas J, Samonigg H. 2003. A common 936 C/T gene polymorphism of vascular endothelial growth factor is associated with decreased breast cancer risk. Int J Cancer. 106:468–71.
   PubMed Web of Science ®Google Scholar
• Kumazaki K, Nakayama M, Suehara N, Wada Y. 2002. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions. Hum Pathol. 33:1069–77.
   PubMed Web of Science ®Google Scholar
• Liberis A, Stanulov G, Chafouz Ali E, Hassan A, Pagalos A, Kontomanolis EN. 2016. Pre-eclampsia and the vascular endothelial growth factor: A new aspect. Clin Exp Obstet Gynecol. 43(1):9–13.
   PubMed Web of Science ®Google Scholar
• Lyall F, Greer IA, Boswel F, Fleming R. 1997. Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol. 104:223–28.
   PubMedGoogle Scholar
• Nabiel Y, Mosbah A. 2019. Maternal serum sEndoglin and cell-free fetal DNA as probable markers of preeclampsia: a study in single center, Egypt. Immunol Invest. 48:608–17.
   PubMed Web of Science ®Google Scholar
• Nagy B, Savli H, Molvarec A, Várkonyi T, Rigó B, Hupuczi P, Rigó J. 2008. Vascular endothelial growth factor (VEGF) polymorphisms in HELLP syndrome patients determined by quantitative real-time PCR and melting curve analyses. Clin Chim Acta. 389:126–31.
   PubMed Web of Science ®Google Scholar
• Odibo AO, Rada CC, Cahill AG, Goetzinger KR, Tuuli MG, Odibo L, Macones GA, England SK. 2013. First-trimester serum soluble fms-like tyrosine kinase-1, free vascular endothelial growth factor, placental growth factor and uterine artery Doppler in preeclampsia. J Perinatol. 33:670–74.
   PubMed Web of Science ®Google Scholar
• Papazoglou D, Galazios G, Koukourakis MI, Panagopoulos I, Kontomanolis EN, Papatheodorou K, Maltezos E. 2004. Vascular endothelial growth factor gene polymorphisms and pre-eclampsia. Mol Hum Reprod. 10:321–24.
   PubMed Web of Science ®Google Scholar
• Peng ML, Tsai YY, Tung JN, Chiang -C-C, Huang Y-C, Lee H, Cheng Y-W. 2014. Vascular endothelial growth factor gene polymorphism and protein expression in the pathogenesis of pterygium. Br J Ophthalmol. 98:556–61.
   PubMed Web of Science ®Google Scholar
• Phipps EA, Thadhani R, Benzing T, Karumanchi, SA. 2019. Pre-eclampsia: pathogenesis, novel diagnostics and therapies. Nat Rev Nephrol. doi:10.1038/s41581-019-0119-6
   Web of Science ®Google Scholar
• Procopciuc LM, Caracostea G, Zaharie G, Stamatian F. 2014. Maternal/newborn VEGF-C936T interaction and its influence on the risk, severity and prognosis of preeclampsia, as well as on the maternal angiogenic profile. J Matern Fetal Neonatal Med. 27:1754–60.
   PubMed Web of Science ®Google Scholar
• Qi WH, Piao SF, Li C, Zhang LJ. 2017. Association of VEGF +936C/T, −634G/C, −2578C/A and −1154G/A polymorphisms with preeclampsia risk in Chinese pregnant women. Int J Clin Exp Med. 10:15391–99.
   Web of Science ®Google Scholar
• Renner W, Kotschan S, Hoffmann C, Obermayer-Pietsch B, Pilger E. 2000. A common 936 C/T mutation in the gene for vascular endothelial growth factor is associated with vascular endothelial growth factor plasma levels. J Vasc Res. 37:443–48.
   PubMed Web of Science ®Google Scholar
• Salimi S, Yaghmaei M, Tabatabaei E, Mokhtari M, Naghavi A. 2015. Vascular endothelial growth factor (VEGF) −634G/C polymorphism was associated with severe pre-eclampsia and lower serum VEGF level. J Obstet Gynaecol Res. 41:1877–83.
   PubMed Web of Science ®Google Scholar
• Sandrim VC, Palei ACT, Cavalli RC, Araújo FM, Ramos ES, Duarte G, Tanus-Santos JE. 2008. Vascular endothelial growth factor genotypes and haplotypes are associated with pre-eclampsia but not with gestational hypertension. Mol Hum Reprod. 15:115–20.
   PubMed Web of Science ®Google Scholar
• Shim JY, Jun JK, Jung BK, Kim SH, Won H-S, Lee PR, Kim A. 2007. Vascular endothelial growth factor gene +936C/T polymorphism is associated with preeclampsia in Korean women. Am J Obstet Gynecol. 197(271):e271–274.
   PubMedGoogle Scholar
• Silva VR, Soardi FC, Tanaka SC, Da Silva-Grecco RL, Paschoini MC, Balarin MAS. 2015. Investigation of polymorphisms in pre-eclampsia related genes VEGF and IL1A. Arch Gynecol Obstet. 291:1029–35.
   PubMed Web of Science ®Google Scholar
• Song GG, Kim JH, Lee YH. 2013. Associations between vascular endothelial growth factor gene polymorphisms and pre-eclampsia susceptibility: a meta-analysis. Immunol Invest. 42:749–62.
   PubMed Web of Science ®Google Scholar
• Sundrani DP, Reddy US, Joshi AA, Mehendale SS, Chavan-Gautam PM, Hardikar AA, Chandak GR, Joshi SR. 2013. Differential placental methylation and expression of VEGF, FLT-1 and KDR genes in human term and preterm preeclampsia. Clin Epigenet. 5:6.
   PubMed Web of Science ®Google Scholar
• Tian YL, Yang HL, Yao SX, Zhai HJ, Han SY. 2017. Association of vascular endothelial growth factor polymorphisms with preeclampsia risk in pregnant women. Biomed Res. 28:6199–204.
   Google Scholar
• Vincenti V, Cassano C, Rocchi M, Persico G. 1996. Assignment of the vascular endothelial growth factor gene to human chromosome 6p21.3. Circulation. 93:1493–95.
   PubMed Web of Science ®Google Scholar
• Watson CJ, Webb NJ, Bottomley MJ, Brenchley PE. 2000. Identification of polymorphisms within the vascular endothelial growth factor (VEGF) gene: correlation with variation in VEGF protein production. Cytokine. 12:1232–35.
   PubMed Web of Science ®Google Scholar
• Young BC, Levine RJ, Karumanchi SA. 2010. Pathogenesis of preeclampsia. Annu Rev Pathol. 5:173–92.
   PubMed Web of Science ®Google Scholar
• Zhang HH, He Y, Zhang CM. 2014. Analysis on single nucleotide polymorphism of vascular endothelial growth factor and susceptibility of preeclampsia patients. Modern Med J. 42:353–57.
   Google Scholar
• Zhang JN, Yu M, Liu LM, Li X, Li HN, Liu J. 2015. Study on the correlation between VEGF−634G/C gene polymorphism and different types of preeclampsia. Maternal Child Health Care China. 30:5470–72.
   Google Scholar
• Zhou L, Huang Y, Hong XP, Liu YL, Xu Y, Xie JS. 2019. Association study between vascular endothelial related gene polymorphism and preeclampsia susceptibility. Chin J Birth Health & Heredity. 27:139–41.
   Google Scholar